ShinJun Kang - Sam-A Pharm Managing Director

009300 Stock  KRW 17,030  430.00  2.59%   

Insider

ShinJun Kang is Managing Director of Sam A Pharm Co
Age 58
Phone82 2 2056 7283
Webhttps://www.samapharm.co.kr

Sam-A Pharm Management Efficiency

The company has return on total asset (ROA) of 0.0117 % which means that it generated a profit of $0.0117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 6.3771 %, meaning that it generated $6.3771 on every $100 dollars invested by stockholders. Sam-A Pharm's management efficiency ratios could be used to measure how well Sam-A Pharm manages its routine affairs as well as how well it operates its assets and liabilities.
Sam A Pharm Co has accumulated 1.51 B in total debt with debt to equity ratio (D/E) of 1.7, which is about average as compared to similar companies. Sam A Pharm has a current ratio of 6.44, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sam-A Pharm until it has trouble settling it off, either with new capital or with free cash flow. So, Sam-A Pharm's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sam A Pharm sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sam-A to invest in growth at high rates of return. When we think about Sam-A Pharm's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

YoonWoo LeeDaihan Pharmaceutical CoLtd
79
MyungKwan SuhKolon Life Science
61
KyungII KimAminologics CoLtd
65
WanJoo KimHLB Pharmaceutical Co
N/A
HunYeol YunAminologics CoLtd
61
SangJun LeeKolon Life Science
62
Dae SonHLB Pharmaceutical Co
46
Jong KimHLB Pharmaceutical Co
58
JungBok YooHLB Pharmaceutical Co
57
DongYeop LeeHLB Pharmaceutical Co
60
InJoong YoonChoong Ang Vaccine
61
WooSok LeeKolon Life Science
66
Dong LeeHLB Pharmaceutical Co
51
MunHee ParkKolon Life Science
N/A
Jeong YooHLB Pharmaceutical Co
48
SangHu ParkKolon Life Science
61
Jeong YoonHLB Pharmaceutical Co
49
Jae NohHLB Pharmaceutical Co
43
TaeHwan KimKolon Life Science
73
Yeong JeonHLB Pharmaceutical Co
45
SangWoo LeeKolon Life Science
59
Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea. Sam A Pharm Co (009300) is traded on KOSDAQ in Korea and employs 287 people.

Management Performance

Sam A Pharm Leadership Team

Elected by the shareholders, the Sam-A Pharm's board of directors comprises two types of representatives: Sam-A Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sam-A. The board's role is to monitor Sam-A Pharm's management team and ensure that shareholders' interests are well served. Sam-A Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sam-A Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
KukHwan Choi, Managing Director
Heo Jun, Chief Officer
HyeonWu Lee, Managing Director
ShinJun Kang, Managing Director
HyeongCheol Nam, Managing Director

Sam-A Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sam-A Pharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Sam-A Pharm

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sam-A Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sam-A Pharm will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sam-A Stock

  0.95074430 Aminologics CoLtdPairCorr

Moving against Sam-A Stock

  0.67030200 KT CorporationPairCorr
  0.55011200 HMM CoPairCorr
  0.47065660 AnterogenCoLtdPairCorr
  0.36023910 Daihan PharmaceuticalPairCorr
The ability to find closely correlated positions to Sam-A Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sam-A Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sam-A Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sam A Pharm Co to buy it.
The correlation of Sam-A Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sam-A Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sam A Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sam-A Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Sam-A Stock

Sam-A Pharm financial ratios help investors to determine whether Sam-A Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam-A with respect to the benefits of owning Sam-A Pharm security.